Optimal treatment of actinic keratoses

Clinical Interventions in Aging

Volumn 8, Issue , 2013, Pages 29-35

  Uhlenhake, Elizabeth E ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Actinic keratosis; Field therapy; Photodynamic therapy; Topical chemotherapy

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; BETA CAROTENE; CELECOXIB; CYCLOOXYGENASE 2; DICLOFENAC; FLUOROURACIL; GAMMA INTERFERON; HYDROCORTISONE; IMIQUIMOD; INGENOL; INTERLEUKIN 12; NICOTINAMIDE; PETROLATUM; RETINOIC ACID; THYMIDYLATE SYNTHASE; TOLL LIKE RECEPTOR 7; TRICHLOROACETIC ACID; TUMOR NECROSIS FACTOR;

ACTINIC KERATOSIS; AGING; APPLICATION SITE DRYNESS; APPLICATION SITE EDEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE PAIN; APPLICATION SITE REACTION; BLUE LIGHT; BREAST CANCER; CRYOTHERAPY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG TARGETING; EVENING DOSAGE; FLU LIKE SYNDROME; HUMAN; INJECTION SITE STINGING; LOW LEVEL LASER THERAPY; LYMPHADENOPATHY; MALIGNANT TRANSFORMATION; PATIENT COMPLIANCE; PATIENT SAFETY; PHOTODYNAMIC THERAPY; PIGMENT DISORDER; PRACTICE GUIDELINE; PRECANCER; PRURITUS; RECTUM CANCER; REVIEW; SKIN ABRASION; SKIN CANCER; SKIN DISEASE; SKIN IRRITATION; SKIN PROTECTION; SKIN REDNESS; SKIN SWELLING; SQUAMOUS CELL CARCINOMA; VESICULAR RASH;

EID: 84873389302     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/cia.s31930     Document Type: Review

References (47)

1. Uhlenhake E, Sangueza OP, Lee AD, Jorizzo JL. Spreading pigmented actinic keratosis: a review. J Am Acad Dermatol. 2010;63(3): 499-506.
2. Warino L, Tusa M, Camacho F, Teuschler H, Fleischer AB Jr, Feldman SR. Frequency and cost of actinic keratosis treatment. Dermatol Surg. 2006;32(8):1045-1049.
3. Stern RS. Dermatologists and office-based care of dermatologic disease in the 21st century. J Investig Dermatol Symp Proc. 2004;9(2): 126-130.
4. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1(8589):795-797.
5. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993;329(16):1147-1151.
6. Darlington S, Williams G, Neale R, Frost C, Green A. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol. 2003;139(4):451-455.
7. Elmets CA, Viner JL, Pentland AP, et al. Chemoprevention of non-melanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst. 2010;102(24):1835-1844.
8. Haddican M, Goldenberg G. Update on the Treatment of Actinic Keratoses. Wayne, PA: Bryn Mawr Communications III LLC; 2012. Available from: http://bmctoday.net/practicaldermatology/pdfs/PD0612_SF_AKs.pdf. Accessed December 5, 2012.
9. Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol. 1982;7(5):631-632.
10. Thai KE, Fergin P, Freeman M, et al. A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol. 2004;43(9):687-692.
11. McIntyre WJ, Downs MR, Bedwell SA. Treatment options for actinic keratoses. Am Fam Physician. 2007;76(5):667-676.
12. Freeman RG, Knox JM, Heaton CL. The treatment of skin cancer. A statistical study of 1,341 skin tumors comparing results obtained with irradiation, surgery, and curettage followed by electrodessication. Cancer. 1964;17:535-538.
13. Ng J, Chong A, Foley P. Destructive management of skin cancers in organ transplant recipients. Cancer Treat Res. 2009;146:447-460.
14. Berman B, Cohen DE, Amini S. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents. Cutis. 2012;89(5):241-250.
15. Jeffes EW 3rd, Tang EH. Actinic keratosis. Current treatment options. Am J Clin Dermatol. 2000;1(3):167-179.
16. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy for actinic keratoses. Arch Dermatol. 2003; 139(10):1313-1320.
17. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42(1 Pt 2):4-7.
18. Berman B, Bienstock L, Kuritzky L, Mayeaux EJ Jr, Tyring SK; Primary Care Education Consortium; Texas Academy of Family Physicians. Actinic keratosis: sequalae and treatments. Recommendations from a consensus panel. J Fam Pract. 2006;55(5):1-8.
19. Ceilley RI. Mechanisms of action of topical 5-fluorouracil: review and implications for the treatment of dermatological disorders. J Dermatolog Treat. 2012;23(2):83-89.
20. Askew DA, Mickan SM, Soyer HP, Wilkinson D. Effectiveness of 5-fluorouracil treatment for actinic keratosis - a systematic review of randomized controlled trials. Int J Dermatol. 2009;48(5):453-463.
21. Breza T, Taylor R, Eaglstein WH. Non-inflammatory destruction of actinic keratoses by fluorouracil. Arch Dermatol. 1976;112(9):1256-1258.
22. Jorizzo J, Stewart D, Bucko A, et al. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis. Cutis. 2002;70(6):335-339.
23. Gupta AK, Cooper EA, Abramovits W. Zyclara (imiquimod) cream, 3.75%. Skinmed. 2010;8(4):227-229.
24. Lebwohl M, Dinehart S, Whiting D, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol. 2004;50(5):714-721.
25. Swanson N, Abramovits W, Berman B, Kulp J, Rigel DS, Levy S. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles. J Am Acad Dermatol. 2010; 62(4):582-590.
26. Lee PK, Harwell WB, Loven KH, et al. Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream. Dermatol Surg. 2005;31(6):659-664.
27. Buckman SY, Gresham A, Hale P, et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis. 1998;19(5):723-729.
28. Subbaramaiah K, Zakim D, Weksler BB, Dannenberg AJ. Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc Soc Exp Biol Med. 1997;216(2):201-210.
29. Rivers JK, Arlette J, Shear N, Guenther L, Carey W, Poulin Y. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol. 2002;146(1):94-100.
30. Siller G, Gebauer K, Welburn P, Katsamas J, Ogbourne SM. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study. Australas J Dermatol. 2009;50(1):16-22.
31. Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012;366(11): 1010-1019.
32. Stritt A, Merk HF, Braathen LR, von Felbert V. Photodynamic therapy in the treatment of actinic keratosis. Photochem Photobiol. 2008;84(2): 388-398.
33. Morton CA. Can photodynamic therapy reverse the signs of photoageing and field cancerization? Br J Dermatol. 2012;167(1):2.
34. Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol. 2005;85(5):424-428.
35. Hantash BM, Stewart DB, Cooper ZA, Rehmus WE, Koch RJ, Swetter SM. Facial resurfacing for nonmelanoma skin cancer prophylaxis. Arch Dermatol. 2006;142(8):976-982.
36. Fulton JE, Rahimi AD, Helton P, Dahlberg K, Kelly AG. Disappointing results following resurfacing of facial skin with CO2 lasers for prophylaxis of keratoses and cancers. Dermatol Surg. 1999;25(9):729-732.
37. Jiang SB, Levine VJ, Nehal KS, Baldassano M, Kamino H, Ashinoff RA. Er: YAG laser for the treatment of actinic keratoses. Dermatol Surg. 2000;26(5):437-440.
38. Jorizzo J, Weiss J, Furst K, VandePol C, Levy SF. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial. Arch Dermatol. 2004;140(7):813-816.
39. Jorizzo JL, Markowitz O, Lebwohl MG, et al. A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses. J Drugs Dermatol. 2010;9(9):1101-1108.
40. Balkrishnan R, Cayce KA, Kulkarni AS, et al. Predictors of treatment choices and associated outcomes in actinic keratoses: results from a national physician survey study. J Dermatolog Treat. 2006;17(3): 162-166.
41. Marrero GM, Katz BE. The new fluor-hydroxy pulse peel. A combination of 5-fluorouracil and glycolic acid. Dermatol Surg. 1998;24(9):973-978.
42. Shaffelburg M. Treatment of actinic keratoses with sequential use of photodynamic therapy; and imiquimod 5% cream. J Drugs Dermatol. 2009;8(1):35-39.
43. Ondo AL, Padilla S, Miedler JD, et al. Treatment-refractory actinic keratoses successfully treated using simultaneous combination topical 5-fluorouracil cream and imiquimod cream: a case-control study. Dermatol Surg. 2012;38(9):1469-1476.
44. Price NM. The treatment of actinic keratoses with a combination of 5-fluorouracil and imiquimod creams. J Drugs Dermatol. 2007;6(8): 778-781.
45. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975-983.
46. Quaedvlieg PJ, Tirsi E, Thissen MR, Krekels GA. Actinic keratosis: how to differentiate the good from the bad ones? Eur J Dermatol. 2006;16(4):335-339.
47. Jeffes EW, McCullough JL, Weinstein GD, Kaplan R, Glazer SD, Taylor JR. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol. 2001;45(1):96-104.